Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Just noticed something interesting happening in European markets right now. Healthcare stocks are having a solid day while broader indices are struggling, and there's actually a solid reason behind this shift.
So here's what's going on. With geopolitical tensions potentially weighing on corporate earnings across Europe, investors are clearly rotating into what you'd call defensive stocks - sectors where demand stays relatively stable regardless of economic conditions. Healthcare is the textbook example here. People need medical services in good times and bad times, so healthcare companies tend to maintain pricing power and can pass costs through to customers without losing business.
I checked the latest sentiment data from European fund managers, and about a quarter of them are now positioning for healthcare outperformance. That's a pretty meaningful shift. You can see it reflected in today's trading too - European healthcare stocks are up 0.8% while the broader STOXX 600 is actually down 0.1%.
What's interesting to me is how this plays out as a defensive stocks strategy. When macro uncertainty rises, this is exactly the kind of rotation we typically see. Healthcare provides that stability investors crave when they're worried about earnings pressure elsewhere. If this trend continues, you might want to keep an eye on how healthcare valuations move relative to the rest of the market.